~~<i id='5315CE6775'><strike id='5315CE6775'><tt id='5315CE6775'><pre id='5315CE6775'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：entertainment 2025-10-01 02:12:22 - browse：49

Damian Garde of STAT talks with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho at STAT in NYC. — Damian Garde of STAT, left, talked with Liisa Bayko of Evercore ISI and Jared Holz of Mizuho about the GLP-1 weight loss market. Michelle C. Gevint for STAT

NEW YORK — Will the world actually soon spend $100 billion a year on the new obesity medicines?

Plenty of people in pharma and at the banks that invest in it seem to think so. Goldman Sachs, Barclays, BMO Capital Markets and Pfizer have all arrived at the glossy, cut-for-headline number for spending by around 2030.

Yet Jared Holz, a healthcare strategist at Mizuho, is skeptical.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： What we need to know about Arena Bioworks

Wikipedia

focus

hotspot

leisure time

focus

AdobeTheCovid-19pandemicisteachingusmanytragiclessonsalongwithsomeinstructiveones,liketheimportanceo

WSS

CDC concerned about possible undetected monkeypox spread in U.K.

The story of mRNA: From a loose idea to a tool that may help curb Covid

The story of mRNA: From a loose idea to a tool that may help curb Covid

Why drug prescriptions should include diagnoses

CDC concerned about possible undetected monkeypox spread in U.K.

The strategy behind pharma's lawsuits over drug pricing reform

focus

leisure time

Wikipedia

How to save PrEP access — and even expand it

Why are elite athletes different? Take a look at their microbes

Supreme Court strikes down use of affirmative action

Do masks work? RCTs can't tell us

Medicare details structure of new drug price negotiation program

Cognito secures funding to test medical device for Alzheimer's

Psychedelics group wrestles with new pharma identity

Do digital therapeutics have a future in medicine?

Cancer drug shortages should be causing more outrage

#NeedHerScience: shining a light on gender disparities in medicine

Wikipedia

Cloning humans is technically possible. It's curious no one has tried

#NeedHerScience: shining a light on gender disparities in medicine

Cloning humans is technically possible. It's curious no one has tried

Novo Nordisk to expand supply of Wegovy for U.S. patients

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Disclosing genetic information: not as worrisome as once feared

focus

hotspot

leisure time

focus